Advancements in Dermatology: A Weekly Review
Dermatologia e Venerologia
Dermatology Breakthroughs: From Psoriasis to Rosacea
This week's episode covers groundbreaking research in dermatology, from consensus guidelines for pustular psoriasis to novel treatments for atopic dermatitis and hidradenitis suppurativa.
Bibliography
1. Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
Authors: Puig L, Carrascosa JM, Rivera R, et al.
Journal: Actas dermo-sifiliograficas, 2026 Mar
PMID: 41371399
DOI: 10.1016/j.ad.2025.104544
2. Association of the Triglyceride-Glucose Index with Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndromes: A Systematic Review and Meta-Analysis.
Authors: Bampali E, Chiotis S, Zgouridou A, et al.
Journal: Medicina (Kaunas, Lithuania), 2026 Feb 11
PMID: 41752760
DOI: 10.3390/medicina62020360
3. The exposomal imprint on rosacea: More than skin deep.
Authors: Grafanaki K, Bakoli Sgourou D, Maniatis A, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Mar
PMID: 41081484
DOI: 10.1111/jdv.70112
4. Nail dystrophy successfully treated with dupilumab in pediatric atopic dermatitis: case series and literature review.
Authors: Wang Q, Liu J, Yang G, et al.
Journal: Frontiers in immunology, 2026
PMID: 41782873
DOI: 10.3389/fimmu.2026.1668182
5. Dermatologic Features of Endocrine Tumor Syndromes-Systematic Review and Meta-Analysis.
Authors: Pálla S, Metyovinyi Z, Meznerics FA, et al.
Journal: International journal of dermatology, 2026 Mar
PMID: 41165034
DOI: 10.1111/ijd.70118
6. Systematic review of the epidemiology of acne vulgaris.
Authors: Heng AHS, Chew FT
Journal: Scientific reports, 2020 Apr 1
PMID: 32238884
DOI: 10.1038/s41598-020-62715-3
7. RB1 inactivation in cutaneous carcinomas.
Authors: Liv T, Touzé A, Schrama D, et al.
Journal: Histopathology, 2026 Mar
PMID: 41395640
DOI: 10.1111/his.70056
8. Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension.
Authors: Sayed CJ, Kirby B, Garg A, et al.
Journal: Journal of the American Academy of Dermatology, 2026 Mar
PMID: 41248770
DOI: 10.1016/j.jaad.2025.11.031
9. Chromoblastomycosis.
Authors: Queiroz-Telles F, de Hoog S, Santos DW, et al.
Journal: Clinical microbiology reviews, 2017 Jan
PMID: 27856522
DOI: 10.1128/CMR.00032-16
10. Targeting IL-22RA1 with temtokibart: A novel approach in atopic dermatitis: Phase 2a monotherapy study results.
Authors: Thaçi D, Laquer V, Lynde C, et al.
Journal: The Journal of allergy and clinical immunology, 2026 Mar
PMID: 41232575
DOI: 10.1016/j.jaci.2025.08.034
Authors: Puig L, Carrascosa JM, Rivera R, et al.
Journal: Actas dermo-sifiliograficas, 2026 Mar
PMID: 41371399
DOI: 10.1016/j.ad.2025.104544
2. Association of the Triglyceride-Glucose Index with Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndromes: A Systematic Review and Meta-Analysis.
Authors: Bampali E, Chiotis S, Zgouridou A, et al.
Journal: Medicina (Kaunas, Lithuania), 2026 Feb 11
PMID: 41752760
DOI: 10.3390/medicina62020360
3. The exposomal imprint on rosacea: More than skin deep.
Authors: Grafanaki K, Bakoli Sgourou D, Maniatis A, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Mar
PMID: 41081484
DOI: 10.1111/jdv.70112
4. Nail dystrophy successfully treated with dupilumab in pediatric atopic dermatitis: case series and literature review.
Authors: Wang Q, Liu J, Yang G, et al.
Journal: Frontiers in immunology, 2026
PMID: 41782873
DOI: 10.3389/fimmu.2026.1668182
5. Dermatologic Features of Endocrine Tumor Syndromes-Systematic Review and Meta-Analysis.
Authors: Pálla S, Metyovinyi Z, Meznerics FA, et al.
Journal: International journal of dermatology, 2026 Mar
PMID: 41165034
DOI: 10.1111/ijd.70118
6. Systematic review of the epidemiology of acne vulgaris.
Authors: Heng AHS, Chew FT
Journal: Scientific reports, 2020 Apr 1
PMID: 32238884
DOI: 10.1038/s41598-020-62715-3
7. RB1 inactivation in cutaneous carcinomas.
Authors: Liv T, Touzé A, Schrama D, et al.
Journal: Histopathology, 2026 Mar
PMID: 41395640
DOI: 10.1111/his.70056
8. Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension.
Authors: Sayed CJ, Kirby B, Garg A, et al.
Journal: Journal of the American Academy of Dermatology, 2026 Mar
PMID: 41248770
DOI: 10.1016/j.jaad.2025.11.031
9. Chromoblastomycosis.
Authors: Queiroz-Telles F, de Hoog S, Santos DW, et al.
Journal: Clinical microbiology reviews, 2017 Jan
PMID: 27856522
DOI: 10.1128/CMR.00032-16
10. Targeting IL-22RA1 with temtokibart: A novel approach in atopic dermatitis: Phase 2a monotherapy study results.
Authors: Thaçi D, Laquer V, Lynde C, et al.
Journal: The Journal of allergy and clinical immunology, 2026 Mar
PMID: 41232575
DOI: 10.1016/j.jaci.2025.08.034
